Royal Belfast Academical Institution

Lab Automation Global Market Report 2022: Amalgamation of AI and Analytical Tools in Laboratory Workflows Presents Opportunities - ResearchAndMarkets.com

Retrieved on: 
Thursday, December 1, 2022
Software, Technology, Biotechnology, Health, Vision Guided Robotic Systems, Hospital, Use, Strategic management, Research, Value, Ortho Clinical Diagnostics, Laboratory information management system, LIMS, Collaborative Drug Discovery, Biotechnology, Customer support, Electronic lab notebook, Market share analysis, Business Growth Fund, Reader-response criticism, Research report, Standardization in Lab Automation, HTS, Robotic arm, COVID-19, Growth, Cumulative distribution function, LES, High-throughput screening, Workcell, Luminescence, Automated pipetting system, Royal Belfast Academical Institution, ASRS, EIA, Acquisition, SDMS, ELN, Compound management, Drug discovery, Automation, Automated storage and retrieval system, Economic development, Climate Monitoring and Diagnostics Laboratory, Equipment, Fine chemical, Retail, Software, Application

The Global Lab Automation Market is projected to grow with a significant CAGR in the forecast period.

Key Points: 
  • The Global Lab Automation Market is projected to grow with a significant CAGR in the forecast period.
  • Further, the patterns associated with domestic production, import and export, and consumption have helped market participants to analyze and capitalize on potential opportunities.
  • Besides, the qualitative and quantitative parameters provided in the report with detailed analysis highlights the driving and restraining factors of the Global Lab Automation Market.
  • The Off-The-Shelf Automated Workcells is further studied across Post-Analytical Automated Systems, Pre-Analytical Automated Systems, and Total Lab Automation Systems.

Global Preclinical CRO Market Report 2022: Increase in R&D Budget for Drug Development Presents Lucrative Opportunities - ResearchAndMarkets.com

Retrieved on: 
Tuesday, August 23, 2022
Health, General Health, Decision-making, Application, Research, Diabetes, Investment, Degenerative disease, Mergers and acquisitions, Royal Belfast Academical Institution, Strategic management, USD, Business Growth Fund, Value, CAGR, Customer support, Government, Use, Market share analysis, News, Gaps, Acquisition, Growth, Toxicology testing, Toxicology, Weakness, Infection, Global, Collaborative partnership, Neurological disorder, Fine chemical, Retail, Bioanalysis

Based on End-user, the market was studied across Biopharmaceutical Companies, Government and Academic Institutes, and Medical Device Companies.

Key Points: 
  • Based on End-user, the market was studied across Biopharmaceutical Companies, Government and Academic Institutes, and Medical Device Companies.
  • Based on Application, the market was studied across Cardiovascular Diseases, Central Nervous System Disorders, Diabetes, Immunological Disorders, Infectious Diseases, Oncology, and Respiratory Diseases.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa.
  • The United States is further studied across California, Florida, Illinois, Massachusetts, Minnesota, New Jersey, New York, Ohio, Pennsylvania, and Texas.

End Stage Renal Disease Global Market Report 2022: Value to Reach $18.06 Billion by 2027 at a CAGR of 16.63% - ResearchAndMarkets.com

Retrieved on: 
Thursday, July 7, 2022
Health, Infectious Diseases, Acquisition, Decision-making, USD, Treatment, Research, Strategic management, Peritoneal dialysis, Market share analysis, User (computing), Business Growth Fund, Value, Dialysis, Customer support, COVID-19, Growth, Collaborative partnership, Transplant, Investment, CAGR, Weakness, Hospital, Kidney, Diagnosis, Use, End Stage Renal Disease Program, Clifton Springs Hospital & Clinic, Royal Belfast Academical Institution, News, Compound annual growth rate, Kidney bean, State, Gaps, Mergers and acquisitions, Medical device, Retail, Blood, Hemodialysis

The "End Stage Renal Disease Market Research Report by Treatment (Dialysis and Transplantation), Diagnosis, End-User, State - United States Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "End Stage Renal Disease Market Research Report by Treatment (Dialysis and Transplantation), Diagnosis, End-User, State - United States Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.
  • The United States End Stage Renal Disease Market size was estimated at USD 7,173.99 million in 2021, USD 8,638.02 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 16.63% to reach USD 18,063.62 million by 2027.
  • This research report categorizes the End Stage Renal Disease to forecast the revenues and analyze the trends in each of the following sub-markets:
    Based on Treatment, the market was studied across Dialysis and Transplantation.
  • Based on Diagnosis, the market was studied across Blood tests, Imaging tests, Kidney sample removal for testing, and Urine tests.